KNT-CT Holdings Co.,Ltd. Logo

KNT-CT Holdings Co.,Ltd.

A travel holding company offering themed tours and corporate travel solutions to boost Japan tourism.

9726 | T

Overview

Corporate Details

ISIN(s):
JP3260400001
LEI:
Country:
Japan
Address:
新宿区西新宿二丁目6番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

KNT-CT Holdings Co., Ltd. is a holding company that oversees a group of 22 companies primarily engaged in the travel and tourism industry. The group's core businesses are operated through its main subsidiaries, Kinki Nippon Tourist and Club Tourism. Kinki Nippon Tourist provides a wide range of travel products and professional consulting services to both corporate and individual clients. Club Tourism is a membership-based organization with seven million members, specializing in planning and selling unique, themed travel products. The holding company focuses on management strategy and administration for the group, with a strategic emphasis on expanding inbound tourism to Japan and contributing to domestic regional revitalization through comprehensive tourism solutions and event management.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-18 08:07
Post-Annual General Meeting Information
臨時報告書
Japanese 27.2 KB
2025-06-16 06:57
Governance Information
内部統制報告書-第88期(2024/04/01-2025/03/31)
Japanese 22.9 KB
2025-06-16 06:56
Registration Form
確認書
Japanese 8.1 KB
2025-06-16 06:54
Annual Report
有価証券報告書-第88期(2024/04/01-2025/03/31)
Japanese 1.6 MB
2025-05-13 09:04
M&A Activity
臨時報告書
Japanese 19.3 KB
2025-05-13 09:03
Board/Management Information
臨時報告書
Japanese 21.4 KB
2025-03-21 03:58
Regulatory News Service
臨時報告書
Japanese 19.8 KB
2024-11-13 01:44
Regulatory News Service
確認書
Japanese 8.1 KB
2024-11-13 01:43
Interim Report
半期報告書-第88期(2024/04/01-2025/03/31)
Japanese 209.2 KB
2024-08-09 08:57
M&A Activity
臨時報告書
Japanese 19.6 KB
2024-06-17 06:06
Post-Annual General Meeting Information
臨時報告書
Japanese 24.7 KB
2024-06-14 07:16
Governance Information
内部統制報告書-第87期(2023/04/01-2024/03/31)
Japanese 22.1 KB
2024-06-14 07:15
Registration Form
確認書
Japanese 8.2 KB
2024-06-14 07:14
Annual Report
有価証券報告書-第87期(2023/04/01-2024/03/31)
Japanese 1.4 MB
2024-02-09 02:21
Report Publication Announcement
確認書
Japanese 8.1 KB

Automate Your Workflow. Get a real-time feed of all KNT-CT Holdings Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KNT-CT Holdings Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KNT-CT Holdings Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Developing novel cancer immunotherapies, including peptide vaccines and iPS-NKT cell therapies.
Japan 4594
Brilliant Future AB Logo
A data-driven survey platform to measure and improve employee & customer experiences.
Sweden BRILL
b-style holdings,Inc. Logo
Offers flexible staffing for homemakers and specialized recruitment for skilled professionals.
Japan 302A
BTS Group Logo
Helps organizations execute strategy via experiential learning for leadership and sales teams.
Sweden BTS
B.U Technology Logo
Commercializes university research via IP management, licensing, and new venture creation.
South Korea 230980
Advancing high-grade copper and precious metal projects from discovery to production.
Canada N/A
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland CTX
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan 6070
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan 4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.